Fundraising Fox
/Companies
Sign in

Exobiosphere

Founded 2024 · 27 employees on LinkedIn · 6 known investors

Find your way into Exobiosphere

Sign up to see every warm intro you have to Exobiosphere

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Exobiosphere team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Exobiosphere is building a standardized space-based high-throughput testing platform that lets pharma and biotech partners run automated experiments in orbit, using microgravity combined with lab automation and bioinformatics to create more physiologically relevant 3D biology models. The company aims to accelerate drug discovery and make space a routine part of the biomedical R&D pipeline.

BiotechDeep TechSpace Tech

Founders & leadership

Exobiosphere was founded in 2024 by Kyle Acierno, Bruno Santos, and Olivia Borgue.

KAKyle Acierno
Kyle AciernoCo-Founder & Chief Executive OfficerHe has over a decade of experience in commercial space exploration, holds a bachelor's degree in International Security and a master's degree in Space Studies, and has held leadership roles across Asia, North America, and Europe.
BSBruno Santos
Bruno SantosCo-Founder & Director of R&DBruno Santos is Co-Founder and Director of R&D at Exobiosphere, where he oversees the development of space-based testing platforms for pharmaceutical and biotech research. He has background expertise in pre-clinical studies, drug development, and lab automation.
OBOlivia Borgue
Olivia BorgueCo-Founder & Director of EngineeringShe has over a decade of engineering experience in spacecraft systems, nuclear R&D, and Antarctic operations, previously leading microgravity hardware development at Yuri and OffWorld, and holds a PhD in space systems engineering.

Investors · 6

Expon Capitallisted by Expon CapitalLuxembourg · $550K – $1.6M

How we know: Expon Capital's portfolio page · a partner's Signal profile · exobiosphere.com · open dataset · 5k.vc investor directory · Not right? Tell us

Also in the syndicate · 4

BoryungCedars-Sinai Technology VenturesSpace DataSpace Data Inc.

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Exobiosphere Secures €1 Million Grant from Luxembourg’s JEI — Exobiosphereexobiosphere.com · Aug 2026Luxembourg’s space BioTech Exobiosphere secures €1 million to find “cures from space”eu-startups.com · Aug 2026Exobiosphere joins the Cedars Sinai Accelerator+ program with a $1.4M Seed Extension investment — Exobiosphereexobiosphere.com · Nov 2025Exobiosphere to Install Orbital High-Throughput Screening Device on Haven-1 Lab — Exobiosphereexobiosphere.com · Apr 2025Exobiosphere raises €2M seed round to bring drug discovery to space — Exobiosphereexobiosphere.com · Apr 2025

Frequently asked questions

What does Exobiosphere do?
Exobiosphere is building a standardized space-based high-throughput testing platform that lets pharma and biotech partners run automated experiments in orbit, using microgravity combined with lab automation and bioinformatics to create more physiologically relevant 3D biology models. The company aims to accelerate drug discovery and make space a routine part of the biomedical R&D pipeline.
Who founded Exobiosphere?
Exobiosphere was founded by Kyle Acierno, Bruno Santos, Olivia Borgue in 2024.
Who are Exobiosphere's investors?
Exobiosphere's investors include Expansion Ventures, Expon Capital.